Can-Fite BioPharma CANF
NYSE CANF
$2.23 +0.03 (+1.36%)
As of: Oct 1, 2026 · 1:35 PM EDT

Can-Fite BioPharma (CANF) Free Cash Flow (2013)

Updated

Can-Fite BioPharma (CANF) reported Free Cash Flow of -$8.95 million for FY2025, compared with -$7.63 million in FY2024.

Analysis

Can-Fite BioPharma (CANF) Free Cash Flow (2013) Analysis & Trends

Dating back to FY2015, Can-Fite BioPharma's Free Cash Flow record includes 11 years.

  • The FY2025 figure ranks as the lowest annual Free Cash Flow since FY2022.
  • According to Business Quant data, Free Cash Flow came in at -$7.63 million in FY2024, -$8.44 million in FY2023, -$10.79 million in FY2022 and -$9.85 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.30 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.11 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 6.20 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 5.34 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.49 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 302.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.01 Bn
10 Can-Fite BioPharma 1.82 Mn -17.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 -1.70 Mn
API Access

Can-Fite BioPharma Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=CANF&period=max&api_key=YOUR_API_KEY